TTUHSC’s Dr. Tyler Mouw Named Medical Director of UMC TLC² Foundation Cancer Center
The Texas Tech University Health Sciences Center (TTUHSC) and UMC Health System announced the appointment of Tyler J. Mouw, M.D., as medical director of the UMC TLC² Foundation Cancer Center. Mouw, who previously served as interim medical director of the cancer center, also serves as division chief of surgical oncology and hepatobiliary surgery at the TTUHSC School of Medicine, chief of surgical oncology at Texas Tech Physicians and the medical director of oncologic surgery at UMC.
“On behalf of UMC Health System, it is my pleasure to announce Dr. Tyler Mouw as medical director of UMC’s TLC2 Foundation Cancer Center,” UMC President and CEO Mark Funderburk said. “Dr. Mouw is a gifted surgical oncologist within the Department of Surgery at the TTUHSC School of Medicine. Dr. Mouw cast a vision to bring innovative treatment to our community, not previously available outside larger cities. Dr. Mouw offers cancer patients a compassionate spirit paired with the latest in technology including – The HIPEC (Hyperthermic Intraperitoneal Chemotherapy) procedure for abdomen cancer and this year – Histotripsy, a non-invasive procedure using focused sound waves to destroy and liquify liver tumors. Dr. Mouw leads a tremendous team of cancer specialists with a singular goal in mind – to provide an exceptional patient experience, founded on clinical expertise, available close to home.”
Through the partnership between UMC and TTUHSC, the UMC TLC2 Foundation Cancer Center connects patients in West Texas and Eastern New Mexico with cutting-edge cancer research and innovative treatments through adult and pediatric clinical trials. This collaboration brings together leading researchers and pharmaceutical innovators to expand access to emerging therapies, advanced technologies and groundbreaking approaches that may not otherwise be available in the region.
“Under Dr. Mouw’s leadership, this specialized cancer center will build on its strengths in collaborative research and innovative treatment to expand access to high-quality cancer care across our 121-county service region,” TTUHSC President Lori Rice-Spearman, Ph.D., said. “His commitment to educating the next generation of healthcare professionals aligns with TTUHSC’s mission and will be instrumental in shaping a healthier future for the people of Texas and Eastern New Mexico, particularly those in rural and underserved communities.”
Mouw received his medical degree from the University of Iowa Roy J. and Lucille A. Carver College of Medicine. He completed a general surgery residency at the University of Kansas Medical Center, followed by fellowship training in complex general surgical oncology and hepatobiliary surgery at the University of Louisville in Kentucky.
In March, Mouw was named the inaugural program director of the John Wayne Cancer Foundation Complex General Surgical Oncology Fellowship. He also serves as the director of the fourth-year sub-internship in surgical oncology at TTUHSC.
Mouw served as co-principal investigator on a $1 million research grant from the Cancer Prevention and Research Institute of Texas (CPRIT) supporting CPRIT FIT Testing. His cancer research contributions include numerous publications, case reports and peer-reviewed abstracts.
Mouw has served as a manuscript reviewer for the Journal of Surgical Oncology since 2019 and was an ad hoc reviewer for The CH Foundation’s research grant review panel in 2024. From 2023 to 2025, he also served as a consultant to government agencies, private industry and other organizations.
Mouw’s primary scholarly work involves the Surgical Outcomes Registry in Cancer (SORC), a research initiative that collects and analyzes cancer-specific and surgical data to advance clinical research. Since joining TTUHSC in 2022, he has developed a research program that engages students in meaningful research opportunities while helping them build the skills to conduct independent clinical studies.
Through this work, Mouw mentors medical students, residents, fellows and other emerging researchers, preparing the next generation of healthcare professionals to advance cancer research and improve patient care.
-30-